Biogen forecasts 2026 profit above Wall Street’s expectations, signaling that steep cost-cutting measures are cushioning the impact of shrinking sales from its multiple sclerosis franchise https://www.bloomberg.com/news/articles/2026-02-06/biogen-s-profit-forecast-tops-estimates-on-cost-cutting-measures?taid=6985cbc9be49b700014b2580&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter